Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer; Propranolol Interventions: Drug: Propranolol hydrochloride; Drug: Sintilimab; Drug: Chemotherapy Sponsors: Second Xiangya Hospital of Central South University; Innovent Biologics (Suzhou) Co. Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Hospitals | Inderal | Lung Cancer | Non-Small Cell Lung Cancer | Research